Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - TOTAL LIABILITIES
Total Liabilities KROS - Keros Therapeutics, Inc.
37.8 M
LAST VALUE
76.94%
2 YEAR CAGR
20.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR